# Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria

> **NCT01659515** · — · NO_LONGER_AVAILABLE · sponsor: **U.S. Army Medical Research and Development Command**

## Conditions studied

- Infection Due to Resistant Organism

## Interventions

- **DRUG:** Arbekacin Sulfate

## Key facts

- **NCT ID:** NCT01659515
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2020-01-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01659515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01659515, "Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01659515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*